scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2184.2008.00577.X |
P8608 | Fatcat ID | release_2ioyq6keevfrjach5kphfxekkm |
P932 | PMC publication ID | 6495736 |
P698 | PubMed publication ID | 19143768 |
P2093 | author name string | K Fujii | |
L Yi | |||
W Yasui | |||
T Sasahira | |||
H Kuniyasu | |||
N Oue | |||
H Ohmori | |||
T Shimomoto | |||
Y Moriwaka | |||
P2860 | cites work | Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue | Q77372895 |
Expression of a novel regenerating gene product, Reg IV, by high density fermentation in Pichia pastoris: production, purification, and characterization | Q79149437 | ||
Reg IV can serve for early diagnosis and therapy | Q79766963 | ||
High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei | Q81563848 | ||
Age-related changes in peptide-23/pancreatitis-associated protein and pancreatic stone protein/reg gene expression in the rat and regulation by growth hormone-releasing hormone | Q28583417 | ||
Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. | Q30664438 | ||
Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. | Q32061478 | ||
Molecular cloning, expression and chromosomal localization of a novel human REG family gene, REG III. | Q33209183 | ||
Expression of the REG IV gene in ulcerative colitis | Q33270662 | ||
Molecular characteristics of eight gastric cancer cell lines established in Japan | Q34099128 | ||
Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas | Q34161211 | ||
Overexpression of Reg IV in colorectal adenoma | Q34269057 | ||
Structural organization and chromosomal localization of a human gene (HIP/PAP) encoding a C-type lectin overexpressed in primary liver cancer | Q34333150 | ||
Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas | Q34372556 | ||
Reg IV: a promising marker of hormone refractory metastatic prostate cancer | Q34406029 | ||
Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas | Q34482693 | ||
Adhesion molecules. | Q34483831 | ||
Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes | Q34581736 | ||
Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer | Q35597399 | ||
Reg gene family and human diseases | Q35605611 | ||
Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers | Q38320984 | ||
Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings | Q38346281 | ||
Anti-tumor effects of liposome-encapsulated titanium dioxide in nude mice | Q40034239 | ||
AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor | Q40132585 | ||
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy | Q40180989 | ||
Peritoneal metastasis inhibition by linoleic acid with activation of PPARgamma in human gastrointestinal cancer cells | Q40338852 | ||
ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention | Q40345488 | ||
Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma | Q40387409 | ||
Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells | Q40434186 | ||
Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. | Q41142896 | ||
Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells | Q41689632 | ||
Cancer statistics, 2003. | Q43729872 | ||
Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells | Q46655503 | ||
Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells | Q47956871 | ||
Frequent amplification of the c-met gene in scirrhous type stomach cancer. | Q53486015 | ||
Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer | Q67510956 | ||
Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis | Q68054454 | ||
Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas | Q72804285 | ||
Aberrant expression of c-met mRNA in human gastric carcinomas | Q72864939 | ||
Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice | Q74376048 | ||
An anti-apoptosis gene, survivin and telomerase expression in gastric cancer | Q74525589 | ||
P433 | issue | 1 | |
P304 | page(s) | 110-121 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | Cell Proliferation | Q1952798 |
P1476 | title | Reg IV enhances peritoneal metastasis in gastric carcinomas | |
P478 | volume | 42 |
Q52657240 | Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinoma. |
Q54290367 | Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer. |
Q36092905 | Expression of MAS1 in breast cancer |
Q35576576 | Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder |
Q55538232 | Expression of Reg IV and SOX9 and their correlation in human gastric cancer. |
Q34419335 | Identification and validation of genes involved in gastric tumorigenesis |
Q33873519 | Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. |
Q34558744 | In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression |
Q26830780 | New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer |
Q54293416 | REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9. |
Q37317423 | REG4 promotes peritoneal metastasis of gastric cancer through GPR37. |
Q38472134 | REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma |
Q38943903 | Regenerating gene family member 4 promotes growth and migration of gastric cancer through protein kinase B pathway. |
Q39568944 | Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer |
Q92443509 | Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer |
Q38028939 | Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers |
Q37448891 | The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer |
Q33510943 | The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target |
Q33700623 | Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV |
Search more.